Geometric deep learning-guided Suzuki reaction conditions assessment for applications in medicinal chemistry.


Journal

RSC medicinal chemistry
ISSN: 2632-8682
Titre abrégé: RSC Med Chem
Pays: England
ID NLM: 101759460

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 21 03 2024
accepted: 25 05 2024
pmc-release: 31 05 2025
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 19 7 2024
Statut: epublish

Résumé

Suzuki cross-coupling reactions are considered a valuable tool for constructing carbon-carbon bonds in small molecule drug discovery. However, the synthesis of chemical matter often represents a time-consuming and labour-intensive bottleneck. We demonstrate how machine learning methods trained on high-throughput experimentation (HTE) data can be leveraged to enable fast reaction condition selection for novel coupling partners. We show that the trained models support chemists in determining suitable catalyst-solvent-base combinations for individual transformations including an evaluation of the need for HTE screening. We introduce an algorithm for designing 96-well plates optimized towards reaction yields and discuss the model performance of zero- and few-shot machine learning. The best-performing machine learning model achieved a three-category classification accuracy of 76.3% (±0.2%) and an

Identifiants

pubmed: 39026644
doi: 10.1039/d4md00196f
pii: d4md00196f
pmc: PMC11253849
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2310-2321

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

G. S. declares a potential financial and non-financial conflict of interest as co-founder of https://inSili.com LLC, Zurich and in his role as a scientific consultant to the pharmaceutical industry. K. A., D. F. N., A. T. M., V. J., M. R. U. G., R. E. M., C. K. and G. W. declare a potential financial and non-financial conflict of interest as full employees of F. Hoffmann-La Roche Ltd.

Auteurs

Kenneth Atz (K)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

David F Nippa (DF)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Alex T Müller (AT)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Vera Jost (V)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Andrea Anelli (A)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Michael Reutlinger (M)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Christian Kramer (C)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Rainer E Martin (RE)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Uwe Grether (U)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Gisbert Schneider (G)

Department of Chemistry and Applied Biosciences, ETH Zurich Vladimir-Prelog-Weg 4 8093 Zurich Switzerland gisbert@ethz.ch.

Georg Wuitschik (G)

Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. Grenzacherstrasse 124 4070 Basel Switzerland kenneth.atz@roche.com georg.wuitschik@roche.com.

Classifications MeSH